Lung Cancer Medical Breakthrough (OTC:BMOD)

Sat, Aug 22, 2009

Home & News, Oral Health

Biomoda, Inc. (Public, OTC: BMOD ) StocksHaven Investments profiles one of the most promising up and coming small cap biotech companies, Biomoda Inc, which has established a medical breakthrough for early lung cancer detection. It is a development-stage company. The Company is an invitro diagnostics company that develops assays, or tests, to detect cancer. These assays are performed in clinical reference laboratories using body-fluid samples. This technology is based on a licensed patent

See the rest here:
Lung Cancer Medical Breakthrough (OTC:BMOD)

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • LinkedIn
  • MySpace
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • NewsVine
, , , , , ,

This post was reviewed by:

Nguyen.Duy

Nguyen.Duy - who has reviewed 252 posts on Better Well-Being.


Comments are closed.